维普中文期刊产品整合服务
23篇 您的检索式:作者名="Ouzan"
    题名 作者 年代 出处 被引量
1Add-on of peg interferon to a stable nucleoside regimen led to loss of HbsAg in chronic hepatitis HBeAg negative patients显示文摘Ouzan D Penaranda G Joly H 0,,1:1
2Optimized stepwise combination algorithms of non - invasive liver fibrosis scores including Hepascore in hepatitis C virus patients 显示文摘Bourliere M Penaranda G Ouzan D 2008Aliment Pharmacol Ther2008,28,4:1
3Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs显示文摘Ouzan D Penaranda G Joly H 2013J Clin Virol2013,58,4:1
4The role of spironolactone in the treatment of patients with refractory hypertension 显示文摘Ouzan J Perault C Lineoff AM 2002Am J Hypertens2002,15,41:1
5The role of spironolactone in the treatment of patients with refractory hypertension显示文摘Ouzan J Perault C Lincoff AM 2002Am J Hypertens2002,15,4:1
6Add-on peg-interfer- on leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs显示文摘Ouzan D P6naranda G Joly H 2013J Clin Virol2013,58,:1
7Porphyria cutanea tank,C282Y,H63D and S65C HFE gene mutations and hepatitis C infection:a study from southern France显示文摘Chiavérini C Halimi G Ouzan D 2003Dermatology2003,206,3:1
8Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including hepascore in hepatitis C virus patients显示文摘Bourliere M Penaranda G Ouzan D 2008Aliment Pharmacol Ther2008,28,4:1
9Add-on peginterferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs 显示文摘Ouzan D Penaranda G Joly H 2013J Clin~irol2013,58,4:1
10The role of spironolactone in the treatment of patients with refractor hypertension显示文摘Ouzan J Perault C Lincoff AM 2002Am J Hypertens2002,15,4:1
11424 OPTIMIZED HBsAg TITER MONITORING IMPROVES INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA显示文摘D. Ouzan G. Pénaranda H. Joly H. Khiri P. Halfon 2013Journal of Hepatology2013,,:1
12The role of spironolactone in the treatment of patients with refractory hypertension显示文摘Ouzan J Perault C Lincoff AM 2002Am J Hypertension2002,15,41:1
13The role of spironolactane in the treatment of patients with refractory hepertonsion显示文摘Ouzan J Perauh C Lincoff AM 2002Am J Hypertons2002,15,41:1
14The role of spironolactone in the treatment of patients with refractory hypertension 显示文摘Ouzan J Perault C Lincoff AM 2002Am J Hypertens2002,15,41:1
15A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus显示文摘Philippe Halfon Marc Bourliere Denis Ouzan Yaakov Maor Christophe Renou Claire Wartelle Guillaume Pénaranda Albert Tran Danielle Botta Valérie Oules Paul Castellani Isabelle Portal Laurent Argiro Alain Dessein 2011European Journal of Gastroenterology & Hepatology2011,,10:1
16Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection:A prospective,real-life,observational study显示文摘AIM: To evaluate the impact of therapeutic education on adherence to antiviral treatment and sustained virological response (SVR) in a real-life setting in genotype 2/3 hepatitis C,as there are few adherence data in genotype 2/3 infection,even from randomized trials.METHODS: This prospective survey included genotype 2/3 patients who received peg-interferon alfa-2b and ribavirin.There was no intervention.Adherence was self-reported over the past 4 wk (peg-interferon) or 7 d (ribavirin).Adherence to bitherapy was defined as adherence to the two drugs for ≥ 20 wk.SVR was defined as undetectable RNA ≥ 12 wk after the end of treatment.RESULTS: 370/674 patients received education during the first 3 mo of treatment.After 6 mo,adherence to bitherapy was higher in educated patients (61% vs 47%,P = 0.01).Adherence to peg-interferon was 78% vs 69% (P = 0.06).Adherence to ribavirin was 70% vs 56% (P = 0.006).The SVR (77% vs 70%,P = 0.05) and relapse (10% vs 16%,P = 0.09) rates tended to be improved.After adjustment for baseline differences,education improved adherence [Odds ratio (OR) 1.58,P = 0.04] but not the SVR (OR 1.54,P = 0.06).CONCLUSION: In genotype 2/3 patients,therapeutic education helped maintain real-life adherence to bitherapy.Patrice Cacoub Denis Ouzan Pascal Melin Jean-Philippe Lang Michel Rotily Thierry Fontanges Marina Varastet Michel Chousterman Patrick Marcellin 2008World Journal of Gastroenterology2008,14,40:1
17A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus显示文摘Philippe Halfon Marc Bourliere Denis Ouzan Yaakov Maor Christophe Renou Claire Wartelle Guillaume Pénaranda Albert Tran Danielle Botta Valérie Oules Paul Castellani Isabelle Portal Laurent Argiro Alain Dessein 2011European Journal of Gastroenterology & Hepatology2011,,10:1
18Risk of transmission of hepatitis C through endoscopy of the digestive tract显示文摘Ouzan D 1999Presse Med1999,28,20:1
19Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs显示文摘Denis Ouzan Guillaume Pénaranda Hélène Joly Hacène Khiri Antonnella Pironti Philippe Halfon 2013Journal of Clinical Virology2013,,4:1
20Optimized stepwise combination algorithms of non -invasive liver fibrosis scores including Hepascore in hepatitis C virus patients显示文摘BOURLIERE M PENARANDA G OUZAN D 2008Ali- ment Pharmacol Ther2008,28,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费